Upload
others
View
20
Download
0
Embed Size (px)
Citation preview
Transfection Fundamentals:Secrets to Success
Anjana Bhattacharya, PhDMirus Bio LLC
2© 2012 Mirus Bio LLC. All rights reserved.
The Transfection Experts
TRANSFECTION
CHEMICAL TRANSFECTION
In Vivo DELIVERY
NUCLEIC ACID TRACKING
ELECTROPORATION
3© 2012 Mirus Bio LLC. All rights reserved.
Pioneering Transfection1996-2012
• THE FIRSTS
• Low toxicity technology that led to the first serum compatible transfection reagent TransIT®-LT1
• First siRNA transfection reagent -TransIT-TKO®
• First serum compatible reagent for large RNA delivery - TransIT®-mRNA
Allternatives
• COMPLEMENTING TRANSFECTION
• Broad spectrum electroporation solution - Ingenio®
• Direct tracking of nucleic acid delivery - Label IT®
Emerging Solutions
2008-2012
• ALWAYS INNOVATING
• High performance animal free reagent - TransIT®-2020
• High yield protein production in suspension cells -TransIT-PRO®
• Biologically relevant transfection – 3D Transfection System
The Transfection Experts
BREAKTHROUGHS in TRANSFECTION
4© 2012 Mirus Bio LLC. All rights reserved.
Transfection Fundamentals
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
5© 2012 Mirus Bio LLC. All rights reserved.
What is Transfection?
(Not Drawn to Scale)
6© 2012 Mirus Bio LLC. All rights reserved.
Transfection Methodologies
Reagent - based
CALCIUM PHOSPHATE
LIPIDS
•Cationic Lipids
•Liposomes
CATIONIC POLYMERS
•Polyethyleneimine
•Basic proteins/peptides
•Dendrimers
•DEAE-dextran
Instrument - based
ELECTROPORATION
OTHER
• Microinjection
• Biolistic delivery
• Magnetic transfectionVirus - mediated
7© 2012 Mirus Bio LLC. All rights reserved.
Simple Transfection Reagent Protocol
8© 2012 Mirus Bio LLC. All rights reserved.
What do we know about how Transfection occurs?
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
9© 2012 Mirus Bio LLC. All rights reserved.
Why do we need Transfection Reagents?
(-) charge (-) charge
=
+
(+) charge
Neutralization of the negative charge& DNA condensation
(+) charge
Transfection Complex Formation
(Not Drawn to Scale)
10© 2012 Mirus Bio LLC. All rights reserved.
What happens during Transfection?
(Not Drawn to Scale)
J Cell Biol. 2008 Jan 14;180(1):7-11
Transfection Complex
11© 2012 Mirus Bio LLC. All rights reserved.
Cationic Lipid
Plasmid DNA
LIPOPLEXES
Net (+) Charge
(Not Drawn to Scale)
O
O
O
NHO
Cl
N
+
Br
DOTAP - 1,2-dioleoyl-3-(trimethyammonium) propane
DDAB - Dimethyldioctadecylammonium(Bromide Salt)
What are Transfection Reagents made up of?Cationic Lipids
12© 2012 Mirus Bio LLC. All rights reserved.
O
O
O
OHO
P
O
O
ONH3
HO
Me
Me
H
H H
Cationic Lipid + Helper Lipid
Plasmid DNA
LIPOSOME MULTI-LAYERED LIPOSOME
(Not Drawn to Scale)
Net (+) Charge
DOPE - Dioleoylphosphatidylethanolamine
Cholesterol
What are Transfection Reagents made up of?Helper Lipids
13© 2012 Mirus Bio LLC. All rights reserved.
What are Transfection Reagents made up of?Cationic Polymers
N+
NH
NN
N
NH2
NH2
NH2
(( ) ) )(( )
Quaternary amine
Primary amineSecondary amine
Tertiary amine
Branched PEI Linear PEI
Cationic Polymer
Plasmid DNA
POLYPLEX(DNA, Polycation)
Net (+) Charge
(Not Drawn to Scale)
Very effective nucleic acid condensing agents
14© 2012 Mirus Bio LLC. All rights reserved.
What are Transfection Reagents made up of?Lipid & Polymer Combinations
Lipid
Cationic Polymer
Plasmid DNA
LIPOPOLYPLEX(DNA, Lipid, Polycation)
Net (+) Charge
(Not Drawn to Scale)
Synergistic combination – Effective condensation and complexation
15© 2012 Mirus Bio LLC. All rights reserved.
Other features of Transfection Complexes
(+) charge
SIZE OF TRANSFECTION COMPLEXES
40 - 1000 nm
CHARGE
Transfection complexes should have a net cationic charge
Positive surface charge density - Zeta potential (+mV)
CHARGE RATIO
N+
NH
NN
N
NH2
NH2
NH2
(( ) ) )(( )
Quaternary amine
Primary amineSecondary amine
Tertiary amine
Branched PEI
16© 2012 Mirus Bio LLC. All rights reserved.
Why Reagent: Nucleic Acid Ratio is important?
N/P ratio = Reagent concentration in Nitrogen residues (mM)
DNA concentration in Phosphate moieties (mM)
Reagent A Reagent B Reagent C
17© 2012 Mirus Bio LLC. All rights reserved.
How to measure Transfection?
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
18© 2012 Mirus Bio LLC. All rights reserved.
Evaluating Transfection Performance
Reporter Systems
Green Fluorescein Protein (GFP)
Luciferase
- galactosidase
Secreted Alkaline Phosphatase(SEAP)
19© 2012 Mirus Bio LLC. All rights reserved.
Visualising Nucleic Acid Delivery Directly
Labeling Nucleic Acid
• Fluorescent labeling
• Non fluorescent tags –Biotin, DNP
20© 2012 Mirus Bio LLC. All rights reserved.
Retaining Function during Nucleic Acid Tracking
Very high labeling efficiencies can • Cause fluorophore quenching• Affect functionality
• Gene expression• Gene knockdown
MOLECULAR THERAPY Vol. 8, No. 2, August 2003
COS-7 cells Rhodamine-labeled DNA expressing nuclear YFP
HeLa cells Fluorescein labeled siRNA
21© 2012 Mirus Bio LLC. All rights reserved.
How to get the best Experimental Output?
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
22© 2012 Mirus Bio LLC. All rights reserved.
Striking the Expression-Toxicity Balance
HeLa cells transfected with plasmid DNA encoding GFP
23© 2012 Mirus Bio LLC. All rights reserved.
Sensitive Assays for Toxicity during Transfection
HeLa cells transfected with plasmid DNA encoding luciferase
Lactate Dehydrogenase (LDH) Assay )Measures membrane leakiness
24© 2012 Mirus Bio LLC. All rights reserved.
What happens inside the cell?
HeLa cells transfected with non-coding plasmidGene expression profile assessed using
qRT-PCR based Human Stress Response 96 StellARray™
25© 2012 Mirus Bio LLC. All rights reserved.
What happens inside the cell?
26© 2012 Mirus Bio LLC. All rights reserved.
Which pathways are affected?
27© 2012 Mirus Bio LLC. All rights reserved.
Different cell types show varied expression/toxicity profiles
28© 2012 Mirus Bio LLC. All rights reserved.
Optimization is key to better results
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
29© 2012 Mirus Bio LLC. All rights reserved.
Transfection WorkflowHow can we improve transfection performance?
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
30© 2012 Mirus Bio LLC. All rights reserved.
Transfection Complex – Media Compatibility
Serum
Antibiotics
Polyanions
Pluronic® F68
Media
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
Transfection Inhibitors
31© 2012 Mirus Bio LLC. All rights reserved.
Serum-free Media affects Transfection
0%
5%
10%
15%
20%
25%
30%
GFP
(%
)
NIH 3T3 cells transfected with a plasmid encoding GFP using TransIT®-LT1
Media
32© 2012 Mirus Bio LLC. All rights reserved.
Protein yields are affected by Media
Applications where final cell densities is important:• Therapeutic Protein
Production - Antibodies Growth factors
CHO-S cells
Media
33© 2012 Mirus Bio LLC. All rights reserved.
Factors affecting Transfection Performance
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
Nucleic Acid
34© 2012 Mirus Bio LLC. All rights reserved.
The Quality of Nucleic Acid
Contaminants, such as protein, carbohydrate and lipids may affect transfection efficiency. Ideal plasmid preparation exhibits an A260/A280 ratio of > 1.8.
Endotoxin contaminated DNA inhibits transfection
COS-7 cells
Nucleic Acid
Use desalted siRNA. Use RNase free kits for purifying mRNA preps to preserve integrity.
35© 2012 Mirus Bio LLC. All rights reserved.
Nucleic Acid Dosage Matters
0.E+00
1.E+07
2.E+07
3.E+07
4.E+07
5.E+07
6.E+07
7.E+07
8.E+07
COS-7 CHO-K1 HEK 293
Lu
cif
era
se
Ac
tiv
ity
(R
LU
s)
3 µl reagent/1 µg DNA
1.2 µl reagent/0.4 µg DNA
TransIT®-LT1 Reagent
Nucleic Acid
COS-7 cells
TransIT-TKO® Reagent
36© 2012 Mirus Bio LLC. All rights reserved.
Different Co-transfection Scenarios
Same Nucleic Acid
Multiple Plasmid DNAsMultiple siRNAsMultiple OligosMultiple mRNAs…
Always premix multiple nucleic acids to prevent preferential complexation with transfection reagent
Choose the molar ratio of nucleic acids carefully
Nucleic Acid
37© 2012 Mirus Bio LLC. All rights reserved.
Different Co-transfection Scenarios
Different Nucleic Acids
Plasmid DNA + siRNA Plasmid DNA + Oligo Plasmid DNA + mRNA…
Mix complexes before adding to cells
Form complexes separately
Plasmid DNA siRNA
Nucleic Acid
38© 2012 Mirus Bio LLC. All rights reserved.
Overexpressing Toxic Proteins
Lower plasmid dosage for the plasmid expressing toxic protein Add empty non-competing cloning vector, e.g. pUC18/19
HeLa cells co-transfected with a plasmidencoding luciferase and empty vector pUC18
Nucleic Acid
39© 2012 Mirus Bio LLC. All rights reserved.
Factors affecting Transfection Performance
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
Complexing Time
40© 2012 Mirus Bio LLC. All rights reserved.
Transfection Complex Formation Time
+ =
(-) charge (+) charge
0.E+00
4.E+07
8.E+07
1.E+08
2.E+08
2.E+08
0 10 20 30 40 50 60
Complex Formation Time (minutes)
Lu
cif
era
se A
cti
vit
y (
RL
Us)
CHO-K1 Cells transfected with a luciferase encoding plasmid using TransIT®-LT1 Reagent
0.E+107
4.0E+107
8.0E+107
1.2E+108
1.6E+108
2.0E+108
Complexing Time
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
0 5 10 15 20
Luci
fera
se E
xpre
ssio
n (R
LUs)
Complex Formation Time (minutes)
CHO-K1 Cells transfected with a capped and polyadenylated luciferase transcriptusing TransIT®-mRNA Transfection Kit
41© 2012 Mirus Bio LLC. All rights reserved.
Factors affecting Transfection Performance
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
Cell culture
42© 2012 Mirus Bio LLC. All rights reserved.
Adherent cell confluency affects transfection
0.E+00
2.E+07
4.E+07
6.E+07
8.E+07
2 3 4 2 3 4
Lu
cif
era
se A
cti
vit
y (
RL
Us)
75% Confluency
100% Confluency
Amount of TransIT®-LT1 Reagent/µg DNA
NIH 3T3 cells transfected with a luciferase encoding plasmid using TransIT®-LT1
COS-7 cells
Cell cultureCell culture
Cell cultureCell culture
Cell culture
43© 2012 Mirus Bio LLC. All rights reserved.
Suspension cell density impacts Transfection
CHO-S suspension adapted cells transfected with a GFP encoding plasmid using TransIT-PRO® Transfection Kit
Cell culture
44© 2012 Mirus Bio LLC. All rights reserved.
Factors affecting Transfection Performance
Media
Nucleic Acid
Complex Formation Time
Cell confluence/density
Harvesting Time
Harvesting Time
45© 2012 Mirus Bio LLC. All rights reserved.
Experimental goals determine harvest time
TYPICAL HARVESTING TIMES
Gene Over-expression 24 - 72 hours
Gene Knockdown 48 - 72 hours
mRNA translation 4 - 24 hours
Protein Production 2 - 14 days
Harvesting Time
46© 2012 Mirus Bio LLC. All rights reserved.
Harvest times affected by nucleic acid turnover
Capped and polyadenylated firefly luciferase mRNA Delivered to NIH3T3 Cells using TransIT®-mRNA Transfection Kit
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
0 6 12 18 24 30 36 42 48
Rel
ativ
e Li
ght
Un
its
Hours Post Transfection
Harvesting Time
47© 2012 Mirus Bio LLC. All rights reserved.
Transfection Results Vary Day to Day
Compare transfection reagents on the same day Follow reagent specific protocols
Harvesting Time
48© 2012 Mirus Bio LLC. All rights reserved.
Transfecting primary and stem cells
Basic Mechanism of Transfection
Evaluating Transfection Performance
Striking the Expression-Toxicity Balance
Optimizing Transfection Output
Making Transfection Physiologically RelevantPrimary and stem cells; 3D transfection
49© 2012 Mirus Bio LLC. All rights reserved.
Primary and stem cells are relevant cellular models
Source : ATCC website
Transfection of mouse embryonic stem cells (mESCs) using TransIT®-LT1
50© 2012 Mirus Bio LLC. All rights reserved.
Nucleic Acid Delivery - A tool for stem cell research
Stem cell reprogramming and differentiation
51© 2012 Mirus Bio LLC. All rights reserved.
mRNA transfection of primary cells to generate iPS cells
BJ fibroblasts transfected with a modified base mRNA encoding GFP using TransIT®-mRNA Transfection Kit
52© 2012 Mirus Bio LLC. All rights reserved.
Transfection of Human iPS cells
Human Induced Pluripotent (iPS) cells transfected with a ZsGreen encoding plasmid
53© 2012 Mirus Bio LLC. All rights reserved.
Electroporation Schema
-+ -
+
(Not Drawn to Scale)
54© 2012 Mirus Bio LLC. All rights reserved.
When to choose Electroporation?
ADVANTAGES– Most efficient method for hard to
transfect cells and non-dividing primary cells
– Universal method for delivering all types of nucleic acids
– Effective on a broad range of cell types
DISADVANTAGES– Requires
Electroporation equipment and cuvettes
Larger numbers of cells Larger amounts of nucleic acid
– Higher cell death– Not suitable for short term (<6 hours)
expression experiments
55© 2012 Mirus Bio LLC. All rights reserved.
Electroporation Workflow and Optimization
Harvest cells
Wash cells and resuspend in Ingenio Solution
Cells
Nucleic Acid
Electroporation Solution
Pulse Conditions
Mix DNA with cells, transfer to cuvette
Electroporate with optimal pulse
Transfer electroporated cells toculture vessel, incubate and harvest
56© 2012 Mirus Bio LLC. All rights reserved.
Electroporation Solution determines Expression/Toxicity
57© 2012 Mirus Bio LLC. All rights reserved.
Ingenio® Electroporation Solution is comparable to Amaxa®
58© 2012 Mirus Bio LLC. All rights reserved.
Transfection of iPS derived iCell® Cardiomyocytes
High efficiency GFP plasmid transfection of iCell® Cardiomyocytesusing TransIT®-LT1 Transfection Reagent
Efficient knockdown of GAPDH expression in iCell® Cardiomyocytesusing TransIT-TKO® Transfection Reagent
59© 2012 Mirus Bio LLC. All rights reserved.
More biologically relevant systems - 3D Transfection
alvetex® 12-well plate alvetex® scaffold cross-section 3D growth of HaCaT cells in alvetex
60© 2012 Mirus Bio LLC. All rights reserved.
More biologically relevant systems - 3D Transfection
GFP expression in a cross-section of NIH 3T3 cells grown and transfected in an alvetex® 12-well plate
Luciferase expression in a variety of cell types grown and transfected in alvetex® 12-well plates
61© 2012 Mirus Bio LLC. All rights reserved.
Experimental Goal – Single most decisive factor
Set-up• Transfection -or- Electroporation
• Different Nucleic Acids
• Gene Over-expression
• Gene knockdown
• Co-transfections???
Output• Imaging
• Flow cytometry
• Western Blots
• Reporter Assays
• QPCR
62© 2012 Mirus Bio LLC. All rights reserved.
Find the videos at our YouTube page
63© 2012 Mirus Bio LLC. All rights reserved.
www.TheTransfectionExperts.com
64© 2012 Mirus Bio LLC. All rights reserved.
Reagent Agent® Transfection Database
65© 2012 Mirus Bio LLC. All rights reserved.
Register for free samples
Email us at [email protected]
Get tested recommendations